Back to top
more

Core Laboratories N.V. (CLB)

(Real Time Quote from BATS)

$33.99 USD

33.99
17,602

+0.82 (2.47%)

Updated May 14, 2021 10:46 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy25.41%
2Buy19.02%
3Hold10.72%
4Sell6.46%
5Strong Sell3.06%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 29% (178 out of 251)

Industry: Oil and Gas - Field Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Trades from $1

Balance Sheet

Research for CLB

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for Core Laboratories N.V. falls in the month of December.

All items in Millions except Per Share data.

12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Assets          
Cash & Equivalents 14 11 13 14 15
Receivables 93 138 143 141 121
Notes Receivable 0 0 0 0 0
Inventories 38 50 46 33 34
Other Current Assets 21 22 29 19 17
Total Current Assets 166 221 231 207 186
Net Property & Equipment 115 124 123 123 130
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 73 67 11 11 21
Intangibles 108 231 232 188 189
Deposits & Other Assets 40 56 51 55 47
Total Assets 569 775 649 585 573
Liabilities & Shareholders Equity 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Notes Payable 0 0 0 0 0
Accounts Payable 23 36 41 42 34
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 33 35 30 36 25
Income Taxes Payable 8 6 3 1 16
Other Current Liabilities 14 23 28 26 29
Total Current Liabilities 90 112 103 105 104
Mortgages 0 0 0 0 0
Deferred Taxes/Income 21 27 8 5 6
Convertible Debt 0 0 0 0 0
Long-Term Debt 259 305 290 227 216
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 67 84 88 99 91
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 493 593 488 436 418
Shareholders Equity 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Preferred Stock 0 0 0 0 0
Common Stock (Par) 1 1 1 1 1
Capital Surplus 41 52 57 54 53
Retained Earnings 50 161 156 174 188
Other Equity -3 -2 -1 -4 -6
Treasury Stock 14 29 53 76 81
Total Shareholder's Equity 76 182 161 149 155
Total Liabilities & Shareholder's Equity 569 775 649 585 573
Total Common Equity 76 182 161 149 155
Shares Outstanding 44.50 44.30 44.20 44.10 44.10
Book Value Per Share 1.70 4.11 3.64 3.37 3.52

Fiscal Year End for Core Laboratories N.V. falls in the month of December.

All items in Millions except Per Share data.

3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020
Assets          
Cash & Equivalents 28 14 15 21 14
Receivables 100 93 93 110 133
Notes Receivable 0 0 0 0 0
Inventories 39 38 43 42 52
Other Current Assets 19 21 18 19 21
Total Current Assets 186 166 170 191 220
Net Property & Equipment 113 115 117 120 123
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 68 73 75 72 71
Intangibles 108 108 108 108 108
Deposits & Other Assets 39 40 52 53 49
Total Assets 584 569 591 614 647
Liabilities & Shareholders Equity 3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020
Notes Payable 0 0 0 0 0
Accounts Payable 26 23 23 24 37
Current Portion Long-Term Debt 0 0 75 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 28 33 39 40 34
Income Taxes Payable 7 8 7 3 5
Other Current Liabilities 13 14 16 20 19
Total Current Liabilities 86 90 172 99 108
Mortgages 0 0 0 0 0
Deferred Taxes/Income 20 21 22 24 24
Convertible Debt 0 0 0 0 0
Long-Term Debt 208 259 190 287 302
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 66 79 81 82
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 438 493 519 548 577
Shareholders Equity 3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020
Preferred Stock 0 0 0 0 0
Common Stock (Par) 1 1 1 1 1
Capital Surplus 103 41 61 61 61
Retained Earnings 58 50 37 35 41
Other Equity -4 -3 -4 -4 -4
Treasury Stock 13 14 24 26 29
Total Shareholder's Equity 146 76 72 66 70
Total Liabilities & Shareholder's Equity 584 569 591 614 647
Total Common Equity 146 76 72 66 70
Shares Outstanding 46.30 44.50 44.50 44.40 44.40
Book Value Per Share 3.15 1.70 1.61 1.49 1.58